[在黑色素瘤辅助和新辅助治疗中的生物标志物]
Julian Kött1,2, Christoffer Gebhardt3,4,5
1Klinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Deutschland.
Dermatologie (Heidelberg, Germany)
|May 7, 2025
概括
个性化黑色素瘤治疗依赖于生物标志物. 组织,血液和成像标记物对精确的患者管理有希望,但需要进一步验证才能广泛临床使用.
科学领域:
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
- 医疗成像医学成像
相关概念视频
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.